Poster highlighting qualigen therapeutics' pan-ras inhibitor platform presented at aacr special conference: advances in breast cancer

Poster includes preclinical data on pan-ras compounds demonstrating inhibition in breast cancer models

QLGN Ratings Summary

QLGN Quant Ranking